By Staff Reporters
***
***
Respiratory syncytial virus (RSV), also called human respiratory syncytial virus (hRSV) and human orthopneumovirus, is a common, contagious virus that causes infections of the respiratory tract. It is a negative-sense, single-stranded RNA virus. Its name is derived from the large cells known as syncytia that form when infected cells fuse.
CITE: https://www.r2library.com/Resource
CDC panel backs Pfizer’s maternal RSV vaccine
A Centers for Disease Control and Prevention advisory committee yesterday recommended administering the vaccine to pregnant people during the third trimester to prevent infants from contracting the virus.
The vaccine is already available, and another RSV vaccine made by AstraZeneca and Sanofi, which is given directly to babies, also won approval recently. RSV sends ~80,000 children under five to US hospitals annually, according to the CDC, and it’s the second leading cause of death for under-one-year-olds globally.
***
COMMENTS APPRECIATED
JOIN US
***
***
Filed under: "Doctors Only", Accounting, Breaking News, Drugs and Pharma, Health Economics, Health Insurance, Healthcare Finance, Professional Liability, Quality Initiatives | Tagged: AstraZeneca, CDC, Pfizer, Respiratory syncytial virus, RSV, Sanofi |
Leave a comment